Free Trial

Fennec Pharmaceuticals (FENC) SEC Filings & 10K Form

Fennec Pharmaceuticals logo
$5.25 -0.34 (-6.08%)
Closing price 04:00 PM Eastern
Extended Trading
$5.25 0.00 (0.00%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Fennec Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/03/2025
6:12 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
6:13 PM
Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 4/A
04/03/2025
6:14 PM
Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4/A
04/03/2025
6:15 PM
Fennec Pharmaceuticals (Issuer)
Sayad Pierre Sargis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
6:16 PM
Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4/A
04/03/2025
5:10 PM
Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
5:11 PM
Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
5:12 PM
Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:17 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:18 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
3:46 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
4:32 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:29 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
5:51 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:53 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:13 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
12:00 PM
Fennec Pharmaceuticals (Subject)
Solas Capital Management, LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
11:06 AM
DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/05/2025
7:24 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:42 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
4:48 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:50 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:46 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:47 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
4:00 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:24 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
3:00 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
6:07 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
6:09 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:06 PM
Fennec Pharmaceuticals (Subject)
RALLIS CHRIS A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
4:02 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:13 PM
Fennec Pharmaceuticals (Issuer)
Sayad Pierre Sargis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:14 PM
Evans Terry L (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:15 PM
Cioffi Christiana Marie (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
6:38 PM
DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
3:46 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
4:30 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
4:30 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
6:00 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:14 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:11 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Warning: “DOGE Collapse” imminent (Ad)

Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.

Click here to see what they’re predicting now.
10/01/2024
4:13 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
4:02 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:33 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:48 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2024
4:30 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4/A
08/26/2024
4:51 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:59 PM
Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:00 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:00 PM
Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:01 PM
Cook Jodi A (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:02 PM
Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
5:56 PM
Fennec Pharmaceuticals (Issuer)
Hackman Jeffrey S. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2024
4:10 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:30 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:21 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
4:55 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:42 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:43 PM
DG Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13G
06/03/2024
5:21 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:12 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:05 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:05 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
4:05 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
4:24 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
3:42 PM
Fennec Pharmaceuticals (Filer)
Form DEF 14A
05/02/2024
3:59 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:15 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4/A
04/22/2024
6:34 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:21 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/18/2024
8:43 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
3:24 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:23 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
5:00 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:15 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/15/2024
5:15 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:28 PM
Fennec Pharmaceuticals (Subject)
Haigh Adrian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
3:19 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
3:46 PM
Fennec Pharmaceuticals (Subject)
Raykov Rosty (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:FENC) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners